Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome

Movement Disorders

Volumn 19, Issue 4, 2004, Pages 397-405

  Evans, Andrew H ^a,b   Katzenschlager, Regina ^a,b   Paviour, Dominic ^a,b   O'Sullivan, John D ^c   Appel, Silke ^a,b   Lawrence, Andrew D ^d   Lees, Andrew J ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

Author keywords

Dopamine dysregulation syndrome; OCD; Parkinson's disease; Punding; Stereotypy

Indexed keywords

AMANTADINE; AMPHETAMINE; APOMORPHINE; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PAROXETINE; PERGOLIDE; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; SELEGILINE;

ADULT; AGED; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; DRUG INDUCED DISEASE; DRUG MEGADOSE; DYSPHORIA; FEMALE; HUMAN; INTERVIEW; IRRITABILITY; MALE; MANIA; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PHENOMENOLOGY; PRIORITY JOURNAL; PUNDING BEHAVIOR; STEREOTYPY;

AGED; COGNITION DISORDERS; DOPAMINE; DOPAMINE AGONISTS; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; LEVODOPA; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OBSESSIVE-COMPULSIVE DISORDER; OCCUPATIONS; PARKINSON DISEASE; STEREOTYPED BEHAVIOR; VIDEOTAPE RECORDING;

EID: 2342442360     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20045     Document Type: Article

References (46)

1. Rylander G. Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr Neurol Neurochir 1972;75:203-212.
2. Schiorring E. Psychopathology induced by "speed drugs." Pharmacol Biochem Behav 1981;14(Suppl.):109-122.
3. Fernandez HH, Friedman JH. Punding on L-dopa. Mov Disord 1999;14:836-838.
4. Friedman JH. Punding on levodopa. Biol Psychiatry 1994;36:350-351.
5. Serrano-Duenas M. Chronic dopamimetic drug addiction and pathologic gambling in patients with Parkinson's disease - presentation of four cases. Ger J Psychiatry 2002;5:62-66.
6. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
7. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000;68:423-428.
8. Parkin SG, Gregory RP, Scott R, Bain P, Silburn P, Hall B, et al. Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: a case series of 115. Mov Disord 2002;17:682-692.
9. Schiorring E. Changes in individual and social behaviour induced by amphetamine and related compounds in monkeys and man. In: Ellinwood EH Jr, Kilbey MM, editors. Cocaine and other stimulants. New York: Plenum Press; 1977. p 481-522.
10. Foa EB, Kozak MJ, Salkovskis PM, Coles ME, Amir N. The validation of a new obsessive-compulsive disorder scale: the Obsessive-Compulsive Inventory. Psychol Assess 1998;10:206-214.
11. Anggard E, Gunne LM, Jonsson LE, Niklasson F. Pharmacokinetic and clinical studies on amphetamine dependent subjects. Eur J Clin Pharmacol 1970;3:3-11.
12. Brady KT, Lydiard RB, Malcolm R, Ballenger JC. Cocaine-induced psychosis. J Clin Psychiatry 1991;52:509-512.
13. Ellinwood EH Jr, Sudilovsky A, Nelson LM. Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry 1973;130:1088-1093.
14. Scher J. Patterns and profiles of addiction and drug abuse. Arch Gen Psychiatry 1966;15:539-551.
15. Meseguer Gancedo E, Garcia Ruiz P. [Punding in Parkinson's disease]. Neurologia 2002;17:228.
16. Rylander G. [Preludin addiction from the clinical and medical-criminological point of view]. Lakartidningen 1966;63:4973-4980.
17. Ellinwood MD. Amphetamine psychosis: a multi-dimensional process. Semin Psychiatry 1969;1:208-226.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press; 1994.
19. Robbins TW, Mittleman G, O'Brien CP, Winn P. The neuropsychological significance of stereotypy induced by stimulant drugs. In: Cooper SJ, Dourish CT, editors. Neurobiology of stereotyped behaviour. Oxford: Clarendon Press; 1990. p 25-63.
20. Garner JP. Mason GJ. Evidence for a relationship between cage stereotypies and behavioural disinhibition in laboratory rodents. Behav Brain Res 2002;136:83-92.
21. Lewis MH, Gluck JP, Beauchamp AJ, Keresztury MF, Mailman RB. Long-term effects of early social isolation in Macaca mulatta: changes in dopamine receptor function following apomorphine challenge. Brain Res 1990;513:67-73.
22. Sahakian BJ, Robbins TW, Morgan MJ, Iversen SD. The effects of psychomotor stimulants on stereotypy and locomotor activity in socially-deprived and control rats. Brain Res 1975;84:195-205.
23. Toates F. The interaction of cognitive and stimulus-response processes in the control of behaviour. Neurosci Biobehav Rev 1998; 22:59-83.
24. Whishaw IQ, Fiorino D, Mittleman G, Castaneda E. Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats. Brain Res 1992;576:1-11.
25. Ikemoto S, Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev 1999;31:6-41.
26. Lawrence AD, Evans AH, Lees AJ. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? Lancet Neurol 2003;2:595-604.
27. Berridge KC, Aldridge JW. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists. Synapse 2000;37:194-204.
28. Randrup A, Munkvad I. Influence of amphetamines on animal behaviour: stereotypy, functional impairment and possible animal-human correlations. Psychiatr Neurol Neurochir 1972;75:193-202.
29. Jentsch JD, Taylor JR. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999;146: 373-390.
30. Volle E, Beato R, Levy R, Dubois B. Forced collectionism after orbitofrontal damage. Neurology 2002;58:488-490.
31. Berridge KC, Aldridge JW. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists. Synapse 2000;37:205-215.
32. Chartoff EH, Marek BT, Matsumoto AM, Dorsa DM, Palmiter RD. Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation. Proc Natl Acad Sci USA 2001;98: 10451-10456.
33. Chen JF, Moratalla R, Impagnatiello F, Grandy DK, Cuellar B, Rubinstein M, et al. The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc Natl Acad Sci USA 2001;98:1970-1975.
34. Nakazato T, Akiyama A. Behavioral activity and stereotypy in rats induced by L-DOPA metabolites: a possible role in the adverse effects of chronic L-DOPA treatment of Parkinson's disease. Brain Res 2002;930:134-142.
35. Graybiel AM, Canales JJ, Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci 2000;23(Suppl.):71-77.
36. Graybiel AM, Rauch SL. Toward a neurobiology of obsessive-compulsive disorder. Neuron 2000;28:343-347.
37. Muller N, Putz A, Kathmann N, Lehle R, Gunther W, Straube A. Characteristics of obsessive-compulsive symptoms in Tourette's syndrome, obsessive-compulsive disorder, and Parkinson's disease. Psychiatry Res 1997;70:105-114.
38. De Marchi N, Morris M, Mennella R, La Pia S, Nestadt G. Association of obsessive-compulsive disorder and pathological gambling with Huntington's disease in an Italian pedigree: possible association with Huntington's disease mutation. Acta Psychiatr Scand 1998;97:62-65.
39. Cheyette SR, Cummings JL. Encephalitis lethargica: lessons for contemporary neuropsychiatry. J Neuropsychiatry Clin Neurosci 1995;7:125-134.
40. Laplane D, Levasseur M, Pillon B, Dubois B, Baulac M, Mazoyer B, et al. Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. Brain 1989; 112:699-725.
41. Lensi P, Cassano GB, Correddu G, Ravagli S, Kunovac JL, Akiskal HS. Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. Br J Psychiatry 1996;169:101-107.
42. Roy A. Obsessive-compulsive neurosis: phenomenology, outcome and a comparison with hysterical neurosis. Compr Psychiatry 1979;20:528-531.
43. Dowson JH. The phenomenology of severe obsessive-compulsive neurosis. Br J Psychiatry 1977;131:75-78.
44. Rauch SL, Dougherty DD, Shin LM, Alpert NM, Manzo P, Leahy L, et al. Neural correlates of factor-analyzed OCD symptom dimensions: a PET study. CNS Spectr 1998;3:37-43.
45. Kelley AE, Stinus L. Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with L-dopa. Behav Neurosci 1985;99:531-545.
46. Lawrence AD. Error correction and the basal ganglia: similar computations for action, cognition and emotion? Trends Cogn Sci 2000;4:365-367.